Build the collagen gummy specification from source to finished-product release.
“Collagen peptides” is not a complete RFQ. A sourcing team should identify whether the concept contains collagen or only a plant-based booster, then lock species and tissue source, supplier material, intended amount, allergen and label requirements, analytical basis, target serving, sensory limits and package assumptions.
Sucotond USA is our factory's U.S. sales and project-coordination office. Products are manufactured by our factory.
At a Glance
Collagen Gummies — technical specification
Use these fields to make the collagen material and finished-product decision auditable; no stock formula is implied.
| Parameter | Specification |
|---|---|
| Species and tissue source | Declared for the requested collagen material and checked against buyer restrictions |
| Material description | Peptide or hydrolysate identity, supplier specification, carrier and relevant processing information |
| Allergen and dietary review | Based on the exact source, complete bill of materials, processing aids and destination-market requirements |
| Amount per serving | Buyer target evaluated against material bulk, piece count, texture and sensory limits |
| Serving and count | Designed after the target material mass is converted into a practical piece and daily serving |
| Gelling system | Selected for the final composition; not used to override the dietary status of the collagen itself |
| Sensory acceptance | Aroma, flavor, chew, finish and appearance criteria agreed for the evaluated sample |
| Label language | Ingredient name, source disclosure, amount, serving and proposed claims reviewed for the destination |
| Package configuration | Container, closure, count and barrier assumptions tested with the final formula |
| Stability decision | Claim period remains pending until protocol, attributes, time points and final package are agreed |
| Commercial terms | MOQ and timing follow material availability, formula feasibility, component readiness, quantity and market review |
Five questions that prevent a misleading collagen RFQ
This is the decision layer usually missing from catalogue pages. Resolve it before comparing piece count, bottle price or production timing.
| Buyer question | What must be written down | Why it changes the project |
|---|---|---|
| Collagen or “booster”? | State whether the formula contains an animal-derived collagen material or a plant-based nutrient blend positioned around normal collagen formation. | They are different ingredient concepts and cannot share the same identity, dietary-positioning or label assumptions. |
| Which source? | Species, tissue/source material, supplier, grade, hydrolyzed or native description, collagen type when substantiated, carrier and processing information. | Source affects allergen review, buyer restrictions, documentation, sensory profile and label language. |
| How much collagen? | Target collagen amount per serving and whether the number refers to collagen itself, a peptide ingredient or the total mass of a multi-component supplier blend. | Blend mass and collagen mass are not automatically interchangeable; the input basis controls serving feasibility and label review. |
| How will it be measured? | Analyte or material basis, reporting unit, gummy matrix, method, method-suitability evidence, sampling point and acceptance criterion. | “Protein test” or “COA included” does not establish that the declared collagen basis is specifically and suitably measured in the finished gummy. |
| Can the serving fit? | Supplier-material mass, other actives, piece weight, daily piece count, target texture and written sensory acceptance limits. | The commercial serving is a formulation output. It should not be copied from a different material or stock SKU. |
Build a collagen source-to-release brief
Turn five buyer-controlled choices into a first evidence path, an open-decision list and minimum review gates before asking for a formula, test plan or quote.
This is a planning organizer, not an approval. It does not establish source identity, allergen or label compliance, method suitability, formula feasibility, shelf life, efficacy or commercial terms.
Selections and copied results stay in this browser.
First evidence path
Open buyer decisions
Minimum evidence gates
The inquiry form contains no selections, result or persistent identity from this tool. Tool selections and results are not submitted with the inquiry form; share only the non-confidential details you choose.
Turn “lab tested” into named evidence
The final plan remains formula- and market-specific. These rows show what the buyer and manufacturer need to agree—not a claim that a particular test has already been completed.
Incoming collagen material
Supplier specification, lot COA, source declaration, traceability and an appropriate component identity verification route.
Finished-product composition
Named collagen basis, method and acceptance criterion, plus any other agreed strength or composition attributes for the finished gummy.
Fish-source label control
When fish-derived collagen is selected, capture the species and route the exact ingredient statement and allergen declaration through U.S. label review.
Sample-to-batch sensory transfer
Record appearance, aroma, flavor, aftertaste, chew and surface criteria on the approved sample and identify the commercial-batch review owner.
Package and stability
Connect container, closure, count and distribution assumptions to a written protocol, attributes, time points and acceptance criteria.
Release ownership
Name who reviews the batch record, test results, deviations and label version before the finished lot is released.
Primary references for the buyer brief
FDA dietary supplement CGMP small-entity guide explains component identity and finished-product specification/testing responsibilities. FDA food-allergen guidance identifies fish as a major allergen and requires the fish species to be declared. AOAC SMPR 2016.005 defines method-performance requirements intended for quantitation of native and hydrolyzed collagen types I–III in dietary ingredients and finished dietary supplements.
These references define regulatory or analytical context. They are not Sucotond test reports, legal advice or evidence that one method is suitable for every gummy matrix.
What actually decides this project
Source identity changes the buyer's obligations
Species, tissue source and supplier material influence sourcing documents, allergen review, dietary-positioning and label language. “Hydrolyzed collagen” or “collagen peptides” can still be too broad for approval. The buyer should state prohibited sources, documentation needs and market before a sample is treated as a viable commercial direction.
Serving mass comes before piece count
The intended collagen amount and the actual supplier material determine how much total material enters a serving. That mass has to coexist with the gelling, acid, sweetener, flavor and moisture system. Piece count should be a result of that review—not a fixed number copied from another SKU. If the target cannot fit an acceptable chew and serving, the specification has to change.
Approve sensory criteria in writing
A color name or flavor name is not an acceptance standard. The project should record aroma, flavor intensity, aftertaste, chew, surface, appearance and any source-related limits on the approved sample. The commercial-transfer plan then identifies which of those attributes must be demonstrated again during scale-up and stability review.
Questions buyers ask about collagen gummies
What collagen material should the buyer specify?
The brief should state species and tissue source, peptide or hydrolysate description, supplier specification, allergen and dietary-positioning requirements and the intended amount per serving.
Can a collagen gummy be called vegetarian or vegan?
Collagen source and every other ingredient must be reviewed before any dietary-positioning statement. A plant-based gelling system would not make an animal-derived collagen product vegetarian or vegan.
What finished-product collagen test should be named?
The project should define the collagen analyte or material basis, reporting unit, gummy matrix, method, method-suitability evidence and acceptance criterion. A generic protein result or an unspecified COA is not a complete collagen release plan.
Does fish collagen require source-specific allergen review?
Yes. FDA identifies fish as a major food allergen and requires the fish species to be declared. The exact material and final U.S. label should be reviewed before artwork approval.
How is packaging selected?
Package type, count, barrier, closure and distribution assumptions are evaluated with the final formula and stability protocol. No package format is promised universally.
When is the minimum order confirmed?
MOQ is confirmed in writing only after collagen material, formula, package components, quantity and destination-market requirements are reviewed.
Other private label gummy lines
Creatine Gummies
Target dose, texture and stability are reviewed for each project.
View specifications →Magnesium Gummies
Ingredient form, elemental basis, serving mass and sensory limits reviewed per project.
View decision fields →CoQ10 Gummies
Material identity, label basis, package and stability evidence reviewed per project.
View decision fields →Vitamin D3 + K2 Gummies
Source, individual amounts, uniformity plan and label requirements reviewed per project.
View decision fields →Custom High-Load Gummies
Active loading is formula-specific and reviewed before tooling.
View specifications →Start your collagen gummies project
Send the collagen species and source, supplier material, intended amount, dietary-positioning limits, destination market, serving concept and package direction. The first review will identify missing material, sensory and label decisions.
Brooklyn, NY 11214